Meditor Group’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $6.26M | Hold |
|
|||||
|
2024
Q2 | $8.42M | Hold |
|
|||||
|
2024
Q1 | $10.2M | Hold |
|
|||||
|
2023
Q4 | $11.3M | Hold |
|
|||||
|
2023
Q3 | $3.72M | Sell |
|
|||||
|
2023
Q2 | $6.12M | Hold |
|
|||||
|
2023
Q1 | $7M | Sell |
|
|||||
|
2022
Q4 | $27.8M | Hold |
|
|||||
|
2022
Q3 | $29.9M | Hold |
|
|||||
|
2022
Q2 | $28.4M | Hold |
|
|||||
|
2022
Q1 | $20.7M | Hold |
|
|||||
|
2021
Q4 | $22.3M | Buy |
|
|||||
|
2021
Q3 | $34M | Hold |
|
|||||
|
2021
Q2 | $59.6M | Buy |
|
|||||
|
2021
Q1 | $75.2M | Hold |
|
|||||
|
2020
Q4 | $69.7M | Hold |
|
|||||
|
2020
Q3 | $99.6M | Hold |
|
|||||
|
2020
Q2 | $138M | Hold |
|
|||||
|
2020
Q1 | $68.1M | Hold |
|
|||||
|
2019
Q4 | $121M | Hold |
|
|||||
|
2019
Q3 | $98.2M | Hold |
|
|||||
|
2019
Q2 | $125M | Hold |
|
|||||
|
2019
Q1 | $108M | Hold |
|
|||||
|
2018
Q4 | $123M | Buy |
|
|||||
|
2018
Q3 | $117M | Hold |
|
|||||
|
2018
Q2 | $103M | Buy |
|
|||||
|
2018
Q1 | $187M | Buy |
|
|||||
|
2017
Q4 | $153M | Buy |
|
|||||
|
2017
Q3 | $115M | Buy |
|
|||||
|
2017
Q2 | $26.2M | Buy |
|